PAM
ADCT icon

Panagora Asset Management’s ADC Therapeutics ADCT Stock Holding History

Panagora Asset Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59M Buy
691,275
+97,019
+16% +$382K 0.01% 538
2025
Q4 		$2.1M Buy
594,256
+49,995
+9% +$203K 0.01% 559
2025
Q3 		$2.18M Buy
544,261
+272,902
+101% +$860K 0.01% 510
2025
Q2 		$727K Buy
271,359
+217,173
+401% +$457K ﹤0.01% 710
2025
Q1 		$76.4K Buy
+54,186
New +$92.1K ﹤0.01% 1085

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Panagora Asset Management's ADCT Position: Q1 2026 in Review

Panagora Asset Management increased its ADC Therapeutics (ADCT) stake by 16% in Q1 2026, buying an estimated $382K and bringing the position to 691,275 shares worth $2.59M. The position accounts for 0.01% of the portfolio, ranked #538.

Panagora Asset Management first reported a position in ADCT in Q1 2025 and has held it in 5 quarters since. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Panagora Asset Management held 691,275 shares of ADC Therapeutics worth $2.59M as of Q1 2026.
  • Panagora Asset Management bought 97,019 ADC Therapeutics shares in Q1 2026, an estimated $382K.
  • ADC Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q1 2026, its #538 holding.
  • Panagora Asset Management first reported a position in ADC Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.